Screening for Cancer: Lessons Learned from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Take Home Message While the PLCO Cancer Screening trial demonstrated no observed mortality benefit associated with screening for prostate cancer with prostate-specific antigen and rectal exam, the knowledge gained about prostate cancer and screening and resources developed in completing the trial ma...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European urology 2015-10, Vol.68 (4), p.545-546
Hauptverfasser:	Grubb, Robert L, Pinsky, Paul, Prorok, Philip C, Andriole, Gerald L
Format:	Artikel
Sprache:	eng
Schlagworte:	Colorectal Neoplasms - diagnosis Colorectal Neoplasms - mortality Early Detection of Cancer - methods Female Humans Lung Neoplasms - diagnosis Lung Neoplasms - mortality Male Ovarian Neoplasms - diagnosis Ovarian Neoplasms - mortality Patient Selection Predictive Value of Tests Prognosis Prostatic Neoplasms - diagnosis Prostatic Neoplasms - mortality Randomized Controlled Trials as Topic Risk Factors Time Factors Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Take Home Message While the PLCO Cancer Screening trial demonstrated no observed mortality benefit associated with screening for prostate cancer with prostate-specific antigen and rectal exam, the knowledge gained about prostate cancer and screening and resources developed in completing the trial make the trial a success.
ISSN:	0302-2838 1873-7560
DOI:	10.1016/j.eururo.2015.04.026